The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|March 1, 2000
The American Journal of Managed Care
- March 2000
- Volume 6
- Issue 3
Cost and Quality under Managed Care: Irreconcilable Differences?
Author(s)Eugene Litvak, PhD, Michael C. Long, MD
Advertisement
Articles in this issue
over 26 years ago
The Cost of Productivity Losses Associated with Allergic Rhinitisover 26 years ago
Current Concepts in the Management of Smoking Cessation: A ReviewAdvertisement
Related to this article
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
Study Finds Possible Deep Endometriosis in 7% of Postmenopausal Women
3
Early-Onset Cancers Often Found Late as Screening Gaps Persist
4
AHIP's Jeanette Thornton on Prior Authorization Reform, Midterms
5